• CDC
  • Heart Failure
  • Cardiovascular Clinical Consult
  • Adult Immunization
  • Hepatic Disease
  • Rare Disorders
  • Pediatric Immunization
  • Implementing The Topcon Ocular Telehealth Platform
  • Weight Management
  • Monkeypox
  • Guidelines
  • Men's Health
  • Psychiatry
  • Allergy
  • Nutrition
  • Women's Health
  • Cardiology
  • Substance Use
  • Pediatrics
  • Kidney Disease
  • Genetics
  • Complimentary & Alternative Medicine
  • Dermatology
  • Endocrinology
  • Oral Medicine
  • Otorhinolaryngologic Diseases
  • Pain
  • Gastrointestinal Disorders
  • Geriatrics
  • Infection
  • Musculoskeletal Disorders
  • Obesity
  • Rheumatology
  • Technology
  • Cancer
  • Nephrology
  • Anemia
  • Neurology
  • Pulmonology

Rx for RLS: What’s the Risk/Benefit Ratio?

Article

Plus, see what you know about parotid masses, thyrotoxic periodic paralysis, new antivirals for hepatitis C, and postpartum neurologic deficits-all topics in this week’s quiz.

 

Question 1:

NEXT QUESTION »


For the discussion, click here.


For the answer, click here.


 

Question 2:

A 40-year-old African American man presented with a 1-year history of bilateral painless swelling in his neck. On palpation, the swelling was non-tender, soft, and mobile but did not feel fluid-filled. Ultrasonograms revealed bilateral parotid masses identified as enlarged parotid glands with multiple 2- to 3-cm cysts present within the glandular tissue.

NEXT QUESTION »


For the discussion, click here.


For the answer, click here.


 

 

Question 3:

NEXT QUESTION »


For the discussion, click here.


For the answer, click here.


 

 

Question 4:

Two directly acting antiviral drugs-boceprevir and telaprevir-are approved for the treatment of hepatitis C virus (HCV) infection.

NEXT QUESTION »


For the discussion, click here.


For the answer, click here.


 

Question 5:

ANSWER KEY »


For the discussion, click here.


 

ANSWER KEY:

Question 1. C

Question 2. C

Question 3. C

Question 4. D

Question 5. F

© 2024 MJH Life Sciences

All rights reserved.